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S iKDificant differences exist in the incidence and clinical characteristics of melanoma found in Japan and the United States. A joint meeting sponsored {,y the National Cancer Institute and the Japanese Society for the Promo­tion of Science was held on November 13-15, 1987, in 
Tokyo to report and compare findings on the comparative biology 
of melanoma in the two countries. It was hoped that new insights 
might be obtained into the development anCl treatment of mela­
noma by contrasting the features in the two populations. A special 
urgency was lent to the project by the recent reports of significant 
increases in the incidence in melanoma in the West, and die possi­
bility that a similar increase was occurring in Japan. Established 
investigators from the two countries discussed their results in epi­
demiology, tumor biology, pathogenesis, biology and behavior of 
precursor lesions, diagnosis,lnc:l methods of control and treatment. 
The incidence rates of melanoma in three distinct geographic 
locations emphasize the enoJ;111OUS differences in the development 
of this tumor between western and eastern groups. For example, the 
incidence of melanoma in Osaka is 0.2/100,OOO/year, while that in 
the United States is approximately:tf1oo,OOO year, and in New 
South Wales, Australia, 17/100,000 year. 
The relationship of nevi, famil' tendencies, and limited risk 
factors was explored as possibly accounting for these differences. 
Following the Cle6nition of the comparative aspects of the problem, 
application of the techniques of cell biology to address these differ­
ences, as well as to report new developments in the melanoma area, 
were featured. 
Results were reported that were intended to clarify the regulatory 
factors responsible for the proliferation and differentiation of mela­
nocytes helping to define factors which might be important to the 
prevention of skin cancer and melanoma. The pathogenesis of mela­
noma was explored with specific emphasis on ultraviolet deets, 
immunologic and oncogenic influences, and the use of pigment 
cells and melanomas in 6sh as models for the human melanomagen­
esis. 
Discussion of the role of precursor lesions focused upon the sig­
ni6cant differences in the type, distribution and biologic potential 
of nevi in Oriental and white groups. These factors were thought to 
account in part for differences in the melanomas seen in the two 
groups. 
A signi6cant portion of the meeting was devoted to the discussion 
of methods of control and treatment. The role of biologic modi6ers 
such as interleukin, interferon, and tumor necrosis factor, speci6c 
immune-based therapies, and melanoma phenotype speci6c thera­
pies were discussed both in scienti6c, as well as clinical, terms. 
In order to share the results of the conference and disseminate the 
information as widely as possible to other clinicians and investiga­
tors in the 6eld, we have collected contributions from the partici­
pants and are reporting them in a special Supplemental Issue of 
The Jounud of InlltStigatiflt Dmruuology. In presenting this publica­
tion, the goafs of the seminar have, in a large part, been realized with 
the recognition that melanoma has now become a major interna­
tional health problem affecting all nations with increasing inci­
dence and mortality. 
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